Tilray Achieves Milestone with First Medical Cannabis License in Germany
Monday, 22 July 2024, 14:13
Introduction to Tilray's License in Germany
Tilray has made a significant stride in the *cannabis* market by securing the first-ever medical growers *license* in Germany. This development opens up new opportunities for expanding production and product variety.
Impact of the New License
- Increased Production: Aphria RX can now raise its production capacity about fivefold.
- Expanded Strain Variety: The company can expand from three to 31 approved *cannabis* strains.
Conclusion
This critical milestone positions Tilray and the German *cannabis* industry for growth, providing greater access to medicinal cannabis options that can assist patients across the country.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.